Diabetic Foot Ulcer Therapeutics Market Insights Video

According to Cognitive Market Research, the global Diabetic Foot Ulcer Therapeutics market size was USD 8614.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.20% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 3445.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2584.35 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1981.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 430.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 172.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
• The dominant segment in the diabetic foot ulcer therapeutics market is neuropathic ulcers. These ulcers result from nerve damage due to uncontrolled diabetes, leading to a loss of sensation in the feet